Medical Robots Transforming Healthcare

Procedure Volume addressed by medical robot is the most important factor influencing the investment in the technology

Selection of right medical robot (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy) is critical for hospitals/care centers/pharmacies and is dependent on number of factors such as capital equipment cost, maintenance and accessories/consumables cost, reimbursements, patient volume catered to, vendor reputation, peer review, and surgeon learning curve/ease of use, among others. Thus, selection of a robot is largely based on the organization’s strategic plan and objectives for adoption of the technology.

Medical robots are high capital purchases with the most common robotic system in the market, the da Vinci system, costing more than USD 1.5 Million. In addition, the annual maintenance cost of a robot is close to USD 125,000, and further sum up to the already high medical costs of a robotic surgery. To add to the high cost various other factors such as declining hospital budgets, improving quality of care delivered, and increasing patient awareness have led to conscious decisions to implement the robotic technologies.

One of the most influencing factors that guide the purchase of the robotic technology is the patient volume that is to be addressed using the technology. Higher the patient volume faster is the break-even achieved. For instance, as per a study, 78 cases per year are needed to cover the costs of a purchased robot (da Vinci), while only 20 cases per year are needed if the robot is donated. However, profit is not feasible at centers performing fewer than 25 cases annually (Study Title: A da Vinci Robot System Can Make Sense for a Mature Laparoscopic Prostatectomy Program, PUBMED - PMC3016020).

Additionally, each technology has a life span of 6 to 12 years (average life span for all types of medical robots). The longer life-span of the equipment provides sufficient time for a healthcare provider to achieve cost-benefits. Contrastingly, the investment in maintenance & replacement of consumables hold-back the full capacity to reach the break-even. For instance, Gamma Knife – a gold standard for removing brain tumors incurs additional expenditure on replacement of cobalt source in every 5 years as the radioactive material is subject to decay. Thus, the factor increasingly features in the consideration sets in the overall purchase mechanism of robotic technologies.

Related Reports:

Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
MD 4248
RI Published ON
4/19/2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Medical Robots Transforming Healthcare
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved